Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Practical aspects of biological throught levels and antidrug antibodies in rheumatoid arthritis and spondyloarthritis
José Rosas; María Martín-López; Teresa Otón; Alejandro Balsa; Jaime Calvo-Alén; Raimon Sanmartí; Jesús Tornero; Loreto Carmona;
Reumatol Clin. 2020;16P2:378-85
How do Spanish Rheumatologists handle referral? Survey of knowledge and approach before and after a training workshop
Alejandro Balsa; Isidoro González-Álvaro; Raimon Sanmartí; Hector Corominas;
Reumatol Clin. 2022;18:564-6
Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price
Mariángeles González Fernández; Elena Villamañán; Inmaculada Jiménez-Nácher; Francisco Moreno; Chamaida Plasencia; Francisco Gayá; Alicia Herrero; Alejandro Balsa;
Reumatol Clin. 2021;17:335-42